ASE’s HCM Guideline in June JASE

The June JASE includes, “Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography,” from Sherif F. Nagueh, MD, FASE, et al. Dr. Nagueh noted that “Updated content in this HCM guideline includes the use of multimodality imaging for the evaluation of patients with left ventricular hypertrophy utilizing new techniques with echocardiography and CMR. There is a new section on the evaluation of HCM patients with ischemia. Other sections that have been updated include role of imaging in the risk stratification of patients for sudden cardiac death.”

Clinical investigations explore vegetation size and surgery in infective endocarditis, pericardial fat and cardiac function, atrial functional tricuspid regurgitation, 3D echocardiography in cardio-oncology, feasibility, reproducibility and prognostic value of automated measurement of RV strain and arterial stiffness and cardiac function in youth-onset diabetes. Papers on pediatric echocardiography explore speckle tracking in children during and after chemotherapy for cardiotoxicity assessment and global longitudinal strain in the single RV.

A response to a Letter to the Editor notes that timely identification of hospitalized patients at risk for COVID-19-associated right heart failure should be a major goal of echocardiographic surveillance in the disease.

The President’s Message from Raymond Stainback, MD, FASE, which is his final communication as he hands the reins over to his successor, looks at his year as the President of ASE, and will give ASE members numerous reasons to be proud of what has been achieved and what is still to come. The continuing education and meeting calendar outlines a multitude of learning options near and far.